Two Different NF1 Pathogenic Variants in a Family With Neurofibromatosis Type 1
Cancer Genomics - Proteomics · 2025
DOI: 10.21873/cgp.20485 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cancer Genomics - Proteomics, 2025. Verfasst von Tabea I Hartung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; t.hartung@uke.de. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Neurofibromin 1, Pedigree. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; t.hartung@uke.de.
- Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Zitieren
APA
Hartung, T. I., Kluwe, L., Friedrich, R. E., & Farschtschi, S. C. (2025). Two Different NF1 Pathogenic Variants in a Family With Neurofibromatosis Type 1. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20485
Vancouver
Hartung TI, Kluwe L, Friedrich RE, Farschtschi SC. Two Different NF1 Pathogenic Variants in a Family With Neurofibromatosis Type 1. Cancer Genomics - Proteomics. 2025. doi:10.21873/cgp.20485
BibTeX
@article{Hartung2025,
author = {Hartung, Tabea I and Kluwe, Lan and Friedrich, Reinhard E and Farschtschi, Said C},
title = {Two Different NF1 Pathogenic Variants in a Family With Neurofibromatosis Type 1},
journal = {Cancer Genomics - Proteomics},
year = {2025},
doi = {10.21873/cgp.20485}
}
EUVIMED